Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob/ob obese mice (Q38325978)

2 September 2017

Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob/ob obese mice (English)

1 reference

2 September 2017

0 references

Linlin Li

1

1 reference

2 September 2017

Yinan Hua

2

1 reference

2 September 2017

Maolong Dong

3

1 reference

2 September 2017

Quan Li

4

1 reference

2 September 2017

Derek T Smith

5

1 reference

2 September 2017

Ming Yuan

6

1 reference

2 September 2017

Kyla R Jones

7

1 reference

2 September 2017

Jun Ren

8

1 reference

2 September 2017

23 April 2012

1 reference

2 September 2017

1 reference

2 September 2017

20

1 reference

2 September 2017

11

1 reference

2 September 2017

2174-2185

1 reference

Obesity as a cardiovascular risk factor

2 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Leptin and hyperleptinemia - from friend to foe for cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Pharmacotherapy of obesity - benefit, bias and hyperbole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Fatty acid-gene interactions, adipokines and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

The metabolic syndrome and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Effects of polyphenolic compounds on tumor necrosis factor-α (TNF-α)-induced changes of adipokines and oxidative stress in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Pharmacological properties of thalidomide and its analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-α and MMP-3 production in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Retracted: Interaction between Age and Obesity on Cardiomyocyte Contractile Function: Role of Leptin and Stress Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Caspase-8 and bid: caught in the act between death receptors and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Recent advances in understanding leptin signaling and leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: Role of oxidative stress, protein carbonyl formation and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

The association between fat and lean mass and bone mineral density: the Healthy Twin Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

A potential role for the myeloid lineage in leptin-regulated bone metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Myocardial overexpression of Mecr, a gene of mitochondrial FAS II leads to cardiac dysfunction in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Underexpression and overexpression of Fas and Fas ligand: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

The apoptotic pathway as a therapeutic target in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Biology of endoplasmic reticulum stress in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Lymphocyte activation in the pathogenesis of psoriasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

TNF-α system and lung function impairment in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

Association between anthropometric measures of obesity, metabolic disturbances and polymorphism G-308A of the tumor necrosis factor-alpha gene in children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.106

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2012.106

1 reference

2 September 2017

1 reference